NCT00921076

Brief Summary

Surgical options for managing hindfoot arthritis include: joint fusion, total ankle joint replacement or osteotomies (realignment) of bones. Fusion of arthritic hindfoot joints has been the accepted method of managing hindfoot arthritis for over a century. Recently, total ankle replacement has evolved as a treatment option for patients with end stage ankle arthritis. A comparison of gait for patients before and after hindfoot fusion or total ankle replacement will give further information about the outcome of this treatment. The principal aim of this project is to assess the effect of total ankle replacement or hindfoot fusion on gait. We are also interested in the outcome of the surgery and its effect on your symptoms (eg. pain and mobility). The results of this study will aid researchers in assessing this new treatment modality. Your involvement in this study is critical for the researchers to further analyze this new form of treatment and your time and involvement is appreciated.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2002

Completed
7 years until next milestone

First Submitted

Initial submission to the registry

June 15, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 16, 2009

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Last Updated

December 13, 2012

Status Verified

July 1, 2009

Enrollment Period

11.6 years

First QC Date

June 15, 2009

Last Update Submit

December 12, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary outcome measure will be micro motion, consisting of component migration and rotation relative to the talus and distal tibia. This will be measured utilizing RSA with bi-planar stereo X-rays taken at several intervals: before weight bearing is

    12 months

Study Arms (2)

Ankle Arthoplasty

ACTIVE COMPARATOR

Patients will undergo a Total Ankle Replacement procedure

Behavioral: Gait Analysis

Ankle fusion

ACTIVE COMPARATOR

Patients will undergo an Ankle Arthrodesis procedure

Behavioral: Gait Analysis

Interventions

Gait AnalysisBEHAVIORAL

A computerized motion analysis system to observe the effect of ankle arthroplasty versus ankle arthrodesis on the kinematic behaviour of the foot and ankle during gait.

Ankle ArthoplastyAnkle fusion

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic Ankle Arthritis
  • Skeletal maturity
  • Able to give informed consent

You may not qualify if:

  • Avascular Necrosis of Talus
  • Obesity (BMI \>30)
  • Prior Ankle fusion or arthroplasty
  • Active or prior infection within 12 months
  • Medical condition precluding major surgery
  • Severe ipsilateral mid or hind foot deformity
  • Severe osteoporotic or osteopenic bone
  • Neuromuscular impairment
  • Age less than 40 years old
  • Cognitive or psychiatric impairment prohibiting accurate follow-up
  • Pregnancy
  • Workers compensation board patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

RECRUITING

MeSH Terms

Interventions

Gait Analysis

Intervention Hierarchy (Ancestors)

GaitPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisPhysical Functional PerformancePhysical FitnessHealthPopulation Characteristics

Study Officials

  • Timothy R. Daniels, MD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Timothy R. Danielst, MD

CONTACT

Ryan M. Khan, BA, CCRP

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2009

First Posted

June 16, 2009

Study Start

June 1, 2002

Primary Completion

January 1, 2014

Last Updated

December 13, 2012

Record last verified: 2009-07

Locations